Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose-Reference-Cited by-同舟云学术

Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose

Published:2010-09 Issue:1-2 Volume:226 Page:150-157
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Cucci Angele,Barbero Pierangelo,Clerico Marinella,Ferrero Bruno,Versino Elisabetta,Contessa Giulia,Demercanti Stefania,Viglietta Emanuela,Di Liberto Alessandra,Vai Alessandra Giai,Durelli Luca

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference48 articles.

1. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy;Becher;Ann. Neurol.,1999

2. Immunological study of IFNbeta-1a-treated and untreated multiple sclerosis patients: clarifying IFN beta mechanisms and establishing specific dendritic cell immunotherapy;Berghella;Neuroimmunomodulation,2005

3. Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production;Byrnes;Ann. Neurol.,2002

4. Interferon beta results in immediate reducion of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI;Calabresi;Neurology,1997

5. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis;Correale;J. Immunol.,1995

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up;Frontiers in Immunology;2022-02-28

2. Investigation of serum vaspin, visfatin, chemerin and IL-18 levels in migraine patients;Arquivos de Neuro-Psiquiatria;2021-09

3. Polymorphisms in proinflammatory cytokines genes and susceptibility to Multiple Sclerosis;Multiple Sclerosis and Related Disorders;2021-01

4. The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple Sclerosis;Cells;2020-06-03

5. Therapeutic Targeting of Chemokines and Chemokine Receptors in Multiple Sclerosis: Opportunities and Challenges;CNS & Neurological Disorders - Drug Targets;2018-08-29